Please use this identifier to cite or link to this item:
Title: Attention deficit hyperactivity disorder across the lifespan
Authors: Camilleri, Nigel
Saliba, Andrea
Calleja Stafrace, Nadine
Keywords: Attention-deficit hyperactivity disorder -- Children
Attention-deficit hyperactivity disorder -- Chemotherapy
Attention-deficit hyperactivity disorder -- Diagnosis
Attention-deficit disorder in adults
Issue Date: 2017
Publisher: Malta College of Pharmacy Practice
Citation: Camilleri, N., Saliba, A., & Calleja Stafrace, N. (2017). Attention deficit hyperactivity disorder across the lifespan. Journal of the Malta College of Pharmacy Practice, 23, 17-24.
Abstract: This article is a research summary of published and non-published work pertaining to Attention Deficit Hyperactivity Disorders (ADHD). ADHD is one of the most common child mental health disorders and is under-recognised in children (5.29%) and adults (2.5%). ADHD is highly heritable with a multifactorial pattern of inheritance. Siblings and parents of a child with ADHD are 4 to 5 times more likely to have ADHD. Methylphenidate is the first line pharmacological treatment with a combined response (this includes trials of other licensed amphetamines) rate of 95%. All clinicians working in mental health should be aware of this disorder, comfortable diagnosing and treating people with ADHD. Young people with untreated ADHD are 5 times more likely to develop antisocial behaviour, substance abuse and other co morbid psychiatric disorders.
Appears in Collections:JMCPP, Issue 23
JMCPP, Issue 23
Scholarly Works - FacM&SPsy

Files in This Item:
File Description SizeFormat 
ISSUE23-5.pdf88.06 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.